Toxoplasma gondii Antibody, IgG
Also known as: TOXEIGG
Use
This test is utilized for detecting prior exposure to Toxoplasma gondii, which is responsible for the infection Toxoplasmosis. A significant change in antibody levels in appropriately timed specimens is the best evidence for current infection. Testing should not be used for blood donor screening, associated re-entry protocols, or for screening human cell, tissues, and cellular- and tissue-based products (HCT/P).
Special Instructions
Not provided.
Limitations
The magnitude of the measured result does not indicate the quantity of antibodies present. Indeterminate results (7.2-8.7 IU/mL) may require repeat testing within 10-14 days for better clarification. This test is not suitable for blood donor screening or associated re-entry protocols.
FDA ApprovedNew York Approved
Methodology
Immunoassay (CLIA)
Biomarkers
Toxoplasma gondii IgG
Antibody
LOINC Codes
- 8039-0 - T gondii IgG Ser-aCnc
Result Turnaround Time
1 day
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
1 mL
Minimum Volume
0.5 mL
Container
Serum separator tube (SST).
Collection Instructions
Allow specimen to clot completely at room temperature. Separate from cells ASAP or within 2 hours of collection.
Causes for Rejection
Contaminated, heat-inactivated, icteric, or grossly hemolyzed specimens.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 48 hours |
| Refrigerated | 2 weeks |
| Frozen | 1 year |
Other tests from different labs that may be relevant